The PI3K-Akt pathway, known for its involvement in regulating cell survival, proliferation, and metabolism, is frequently dysregulated in breast cancer (Miricescu et al., 2020; Zhu et al., 2022; Sharma et al., 2017). This evidence concerns the gene AKT1 and breast carcinoma.